Cargando…
CD40 in coronary artery disease: a matter of macrophages?
Coronary artery disease (CAD), also known as ischemic heart disease (IHD), is the leading cause of mortality in the western world, with developing countries showing a similar trend. With the increased understanding of the role of the immune system and inflammation in coronary artery disease, it was...
Autores principales: | Jansen, Matthijs F., Hollander, Maurits R., van Royen, Niels, Horrevoets, Anton J., Lutgens, Esther |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856717/ https://www.ncbi.nlm.nih.gov/pubmed/27146510 http://dx.doi.org/10.1007/s00395-016-0554-5 |
Ejemplares similares
-
Cellular and Pharmacological Targets to Induce Coronary Arteriogenesis
por: Hollander, Maurits R., et al.
Publicado: (2014) -
Stimulation of Collateral Vessel Growth by Inhibition of Galectin 2 in Mice Using a Single‐Domain Llama‐Derived Antibody
por: Hollander, Maurits R., et al.
Publicado: (2019) -
Anti-Galectin-2 Antibody Treatment Reduces Atherosclerotic Plaque Size and Alters Macrophage Polarity
por: Kane, Jamie, et al.
Publicado: (2022) -
Expression of a retinoic acid signature in circulating CD34 cells from coronary artery disease patients
por: van der Pouw Kraan, Tineke CTM, et al.
Publicado: (2010) -
CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease—The Pros and Cons for Cardioprotection
por: Daub, Steffen, et al.
Publicado: (2020)